US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist

3.4200
-0.0200-0.58%

Close Jun 7 16:00 ET

3.4897
+0.0697+2.04%

Post 18:10 ET

479.73MMarket Cap-22800P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

13.59%-7.99M

56.72%-21.13M

-7.48M

-9.25M

-590.46%-48.82M

81.69%-7.07M

35.87%-38.62M

-174.19%-60.22M

31.68%-21.96M

-8.38%-32.15M

Net income from continuing operations

25.88%-8.95M

30.21%-29.47M

---2.98M

---12.08M

-319.66%-42.22M

108.47%19.22M

-320.76%-226.84M

-44.51%-53.91M

20.54%-37.31M

-39.23%-46.95M

Operating gains losses

-124.81%-165K

117.50%2.1M

--491.62K

--665K

77.30%-12.01M

-131.68%-52.9M

7,121.50%167M

-4,200.78%-2.38M

-95.81%58K

161.17%1.38M

Depreciation and amortization

21.15%275K

19.35%1.06M

--282.57K

--227K

2.60%889K

-60.24%866.47K

5.39%2.18M

5,201.82%2.07M

8.33%39K

9.29%36K

Other non cash items

537.14%306K

-12.51%1.84M

--939.04K

---70K

-88.38%2.1M

154.15%18.1M

502.09%7.12M

-49.13%1.18M

784.03%2.33M

46.30%263K

Change In working capital

-505.93%-1.51M

32.27%-1.59M

---8.4M

--371K

5.55%-2.35M

46.42%-2.49M

53.77%-4.65M

-517.76%-10.05M

-20.33%2.41M

251.94%3.02M

-Change in receivables

4.41%-477K

113.15%456K

---6.46M

---499K

-336.14%-3.47M

-513.69%-794.94K

115.66%192.16K

-252.64%-1.23M

195.71%804K

31.10%-840K

-Change in prepaid assets

-41.10%1.94M

-5.64%502K

----

--3.29M

--532K

----

-Change in payables and accrued expense

-23.01%-2.81M

-235.04%-1.97M

--1.22M

---2.29M

186.19%1.46M

64.97%-1.7M

45.16%-4.84M

-650.82%-8.82M

-58.50%1.6M

602.34%3.86M

-Change in other current liabilities

-14.71%-156K

34.17%-578K

----

---136K

---878K

----

Cash from discontinued investing activities

Operating cash flow

13.59%-7.99M

56.72%-21.13M

---7.48M

---9.25M

-590.46%-48.82M

81.69%-7.07M

35.87%-38.62M

-160.27%-60.22M

28.03%-23.14M

-8.38%-32.15M

Investing cash flow

Cash flow from continuing investing activities

-67.06%-700K

-121.09%-419K

584.23K

-419K

449.70%1.99M

-127.89%-568.2K

-96.41%2.04M

22,426.56%56.77M

106.73%252K

-1,104.79%-3.74M

Net PPE purchase and sale

----

--0

----

375.19%1.99M

-3,211.39%-722.06K

20.81%-21.81K

19.02%-27.53K

-112.50%-34K

-598.08%-16K

Net intangibles purchase and sale

-67.06%-700K

---419K

---6.06K

---419K

--0

-93.85%152.51K

--2.48M

--0

---2.28M

Net business purchase and sale

----

--0

-103.65%-482.44K

--13.21M

--0

Net investment purchase and sale

----

--43.09M

--0

---2.5M

Cash from discontinued investing activities

Investing cash flow

-67.06%-700K

-121.09%-419K

--584.23K

---419K

449.70%1.99M

-127.89%-568.2K

-96.41%2.04M

22,426.56%56.77M

106.73%252K

-1,104.79%-3.74M

Financing cash flow

Cash flow from continuing financing activities

3,886.50%7.97M

-99.81%200K

121.38%104.8M

732.32%47.34M

-260.81%-7.49M

-106.15%-2.08M

-50.64%33.74M

Net issuance payments of debt

----

---3.19M

----

-103.05%-933.95K

1,156.64%30.65M

-737.43%-2.9M

-97.73%455K

477.44%20M

Net common stock issuance

----

--11.61M

----

--0

286.23%105.99M

2,197.13%27.44M

-3,748.66%-1.31M

-100.23%-34K

-77.91%15M

Cash dividends paid

----

--0

Proceeds from stock option exercised by employees

----

--62.08K

--0

----

Net other financing activities

----

-322.00%-444K

----

163.33%200K

95.35%-315.82K

-581.00%-6.8M

-17.25%-997.8K

8.49%-851K

68.96%-930K

Cash from discontinued financing activities

Financing cash flow

----

3,886.50%7.97M

----

-99.81%200K

121.38%104.8M

732.32%47.34M

-260.81%-7.49M

-106.15%-2.08M

-50.64%33.74M

Net cash flow

Beginning cash position

-15.78%57.42M

-46.48%68.18M

--59.81M

--68.18M

302.21%127.4M

42.18%31.67M

-32.15%22.28M

-34.39%32.83M

-6.59%50.05M

337.44%53.58M

Current changes in cash

10.10%-8.69M

70.88%-13.58M

---8.05M

---9.67M

-148.00%-46.63M

803.50%97.16M

198.27%10.75M

56.16%-10.94M

-1,061.02%-24.96M

-105.50%-2.15M

Effect of exchange rate changes

-105.41%-70K

122.40%2.82M

---1.51M

--1.29M

-700.22%-12.58M

-50.03%-1.57M

-129.03%-1.05M

-1,016.09%-457.6K

97.04%-41K

-161.12%-1.38M

End cash Position

-18.64%48.66M

-15.78%57.42M

--53.12M

--59.81M

-46.43%68.18M

297.90%127.27M

49.22%31.98M

-14.41%21.43M

-49.96%25.04M

-6.59%50.05M

Free cash flow

10.10%-8.69M

55.87%-21.55M

---7.49M

---9.67M

-526.66%-48.83M

79.84%-7.79M

35.86%-38.65M

-160.00%-60.25M

32.72%-23.17M

-16.11%-34.45M

Currency Unit

USD

GBP

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	13.59%-7.99M	56.72%-21.13M	-7.48M	-9.25M	-590.46%-48.82M	81.69%-7.07M	35.87%-38.62M	-174.19%-60.22M	31.68%-21.96M	-8.38%-32.15M
Net income from continuing operations	25.88%-8.95M	30.21%-29.47M	---2.98M	---12.08M	-319.66%-42.22M	108.47%19.22M	-320.76%-226.84M	-44.51%-53.91M	20.54%-37.31M	-39.23%-46.95M
Operating gains losses	-124.81%-165K	117.50%2.1M	--491.62K	--665K	77.30%-12.01M	-131.68%-52.9M	7,121.50%167M	-4,200.78%-2.38M	-95.81%58K	161.17%1.38M
Depreciation and amortization	21.15%275K	19.35%1.06M	--282.57K	--227K	2.60%889K	-60.24%866.47K	5.39%2.18M	5,201.82%2.07M	8.33%39K	9.29%36K
Other non cash items	537.14%306K	-12.51%1.84M	--939.04K	---70K	-88.38%2.1M	154.15%18.1M	502.09%7.12M	-49.13%1.18M	784.03%2.33M	46.30%263K
Change In working capital	-505.93%-1.51M	32.27%-1.59M	---8.4M	--371K	5.55%-2.35M	46.42%-2.49M	53.77%-4.65M	-517.76%-10.05M	-20.33%2.41M	251.94%3.02M
-Change in receivables	4.41%-477K	113.15%456K	---6.46M	---499K	-336.14%-3.47M	-513.69%-794.94K	115.66%192.16K	-252.64%-1.23M	195.71%804K	31.10%-840K
-Change in prepaid assets	-41.10%1.94M	-5.64%502K	----	--3.29M	--532K	----	----	----	----	----
-Change in payables and accrued expense	-23.01%-2.81M	-235.04%-1.97M	--1.22M	---2.29M	186.19%1.46M	64.97%-1.7M	45.16%-4.84M	-650.82%-8.82M	-58.50%1.6M	602.34%3.86M
-Change in other current liabilities	-14.71%-156K	34.17%-578K	----	---136K	---878K	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	13.59%-7.99M	56.72%-21.13M	---7.48M	---9.25M	-590.46%-48.82M	81.69%-7.07M	35.87%-38.62M	-160.27%-60.22M	28.03%-23.14M	-8.38%-32.15M
Investing cash flow
Cash flow from continuing investing activities	-67.06%-700K	-121.09%-419K	584.23K	-419K	449.70%1.99M	-127.89%-568.2K	-96.41%2.04M	22,426.56%56.77M	106.73%252K	-1,104.79%-3.74M
Net PPE purchase and sale	----	--0	----	----	375.19%1.99M	-3,211.39%-722.06K	20.81%-21.81K	19.02%-27.53K	-112.50%-34K	-598.08%-16K
Net intangibles purchase and sale	-67.06%-700K	---419K	---6.06K	---419K	--0	-93.85%152.51K	--2.48M	--0	--0	---2.28M
Net business purchase and sale	----	----	----	----	----	--0	-103.65%-482.44K	--13.21M	--0	--0
Net investment purchase and sale	----	----	----	----	----	----	----	--43.09M	--0	---2.5M
Cash from discontinued investing activities
Investing cash flow	-67.06%-700K	-121.09%-419K	--584.23K	---419K	449.70%1.99M	-127.89%-568.2K	-96.41%2.04M	22,426.56%56.77M	106.73%252K	-1,104.79%-3.74M
Financing cash flow
Cash flow from continuing financing activities		3,886.50%7.97M			-99.81%200K	121.38%104.8M	732.32%47.34M	-260.81%-7.49M	-106.15%-2.08M	-50.64%33.74M
Net issuance payments of debt	----	---3.19M	----	----	----	-103.05%-933.95K	1,156.64%30.65M	-737.43%-2.9M	-97.73%455K	477.44%20M
Net common stock issuance	----	--11.61M	----	----	--0	286.23%105.99M	2,197.13%27.44M	-3,748.66%-1.31M	-100.23%-34K	-77.91%15M
Cash dividends paid	----	----	----	----	----	--0	--0	--0	--0	--0
Proceeds from stock option exercised by employees	----	----	----	----	----	--62.08K	--0	--0	----	----
Net other financing activities	----	-322.00%-444K	----	----	163.33%200K	95.35%-315.82K	-581.00%-6.8M	-17.25%-997.8K	8.49%-851K	68.96%-930K
Cash from discontinued financing activities
Financing cash flow	----	3,886.50%7.97M	----	----	-99.81%200K	121.38%104.8M	732.32%47.34M	-260.81%-7.49M	-106.15%-2.08M	-50.64%33.74M
Net cash flow
Beginning cash position	-15.78%57.42M	-46.48%68.18M	--59.81M	--68.18M	302.21%127.4M	42.18%31.67M	-32.15%22.28M	-34.39%32.83M	-6.59%50.05M	337.44%53.58M
Current changes in cash	10.10%-8.69M	70.88%-13.58M	---8.05M	---9.67M	-148.00%-46.63M	803.50%97.16M	198.27%10.75M	56.16%-10.94M	-1,061.02%-24.96M	-105.50%-2.15M
Effect of exchange rate changes	-105.41%-70K	122.40%2.82M	---1.51M	--1.29M	-700.22%-12.58M	-50.03%-1.57M	-129.03%-1.05M	-1,016.09%-457.6K	97.04%-41K	-161.12%-1.38M
End cash Position	-18.64%48.66M	-15.78%57.42M	--53.12M	--59.81M	-46.43%68.18M	297.90%127.27M	49.22%31.98M	-14.41%21.43M	-49.96%25.04M	-6.59%50.05M
Free cash flow	10.10%-8.69M	55.87%-21.55M	---7.49M	---9.67M	-526.66%-48.83M	79.84%-7.79M	35.86%-38.65M	-160.00%-60.25M	32.72%-23.17M	-16.11%-34.45M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	GBP	GBP
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	Unqualified Opinion	--	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall